FDA issues warning over Philips fetal monitors

Justine Varieur Cadet | | Health Imaging | Screening
The FDA has issued a letter to notify healthcare professionals and facilities of a number of complaints of inaccurate readings when using the Philips Healthcare Avalon fetal monitors, models FM20, FM30, FM40, and FM50 with the ultrasound transducer to measure fetal heart rate.

On Sept. 4, Philips issued an important device safety alert. Inaccurate output readings, if not properly addressed, may lead to unnecessary interventions, failure to identify the need for interventions and failure to identify fetal distress, according to the company.

The complaints most commonly occur during the second stage of labor, the agency reported. Philips received a number of complaints of inaccurate output readings that prompted this alert.

Justine Varieur Cadet

Related Content

Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.